Literature DB >> 15052263

New therapeutic key for cystic fibrosis: a role for lipoxins.

Daiya Takai, Takahide Nagase, Takao Shimizu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15052263     DOI: 10.1038/ni0404-357

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  5 in total

1.  Phagocytic clearance of apoptotic cells: role in lung disease.

Authors:  Jeong H Yun; Peter M Henson; Rubin M Tuder
Journal:  Expert Rev Respir Med       Date:  2008-12       Impact factor: 3.772

Review 2.  Omics approaches in cystic fibrosis research: a focus on oxylipin profiling in airway secretions.

Authors:  Jason P Eiserich; Jun Yang; Brian M Morrissey; Bruce D Hammock; Carroll E Cross
Journal:  Ann N Y Acad Sci       Date:  2012-07       Impact factor: 5.691

3.  Neutrophil unsaturated fatty acid release by GM-CSF is impaired in cystic fibrosis.

Authors:  Elena Bravo; Mariarosaria Napolitano; Sara Benedetti Valentini; Serena Quattrucci
Journal:  Lipids Health Dis       Date:  2010-11-08       Impact factor: 3.876

4.  Metabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients.

Authors:  Jun Yang; Jason P Eiserich; Carroll E Cross; Brian M Morrissey; Bruce D Hammock
Journal:  Free Radic Biol Med       Date:  2012-05-08       Impact factor: 7.376

5.  Novel biphasic role of LipoxinA(4) on expression of cyclooxygenase-2 in lipopolysaccharide-stimulated lung fibroblasts.

Authors:  Shengxing Zheng; Qian Wang; Qian He; Xiaorong Song; Duyun Ye; Fang Gao; Shengwei Jin; Qingquan Lian
Journal:  Mediators Inflamm       Date:  2011-07-02       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.